What Happened?
Durham, NC-based Chimerix Promoted Roy Ware as Chief Manufacturing and Technology Officer
About the Company
Chimerix is a biopharmaceutical company dedicated to discovering, developing and commercializing medicines that improve outcomes for immunocompromised patients. Chimerix`s proprietary lipid conjugate technology has produced brincidofovir (BCV, CMX001); CMX157, which was licensed to ContraVir Pharmaceuticals; and earlier-stage clinical candidates. Chimerix recently announced a new clinical candidate, CMX521, for the treatment and/or prevention of norovirus.
About the Person
Roy Ware is chief manufacturing and technology officer at Chimerix. Previously, Roy held various senior HR leadership roles in the industry.
Info Source
News
Short Profile